MiMedx Group, Inc. Securities Fraud Class Action

VIEW COMPLAINT

Please complete this form and list your purchase and sale transaction(s) MiMedx Group, Inc. (“MiMedx”) (Nasdaq: MDXG) securities between March 7, 2013 and February 21, 2018, both dates inclusive (the “Class Period”).

You may also contact James Maro, Esq. at (484) 270-1453; or you may submit your information via email at info@ktmc.com, or you may click here to print a PDF of this form.

Information Sheet

* Denotes required field

First Name *

Last Name *

Email *

Country

City

State\Province

Zip\Postal Code

Country Prefix

Phone Number

Phone Type

Purchase(s)

+ Additional Purchases

Sale(s)

+ Additional Sales

Date

# of Shares

Price per Share

Date

Principal Amount

Amount Paid

Series or CUSIP

Date

# of Contracts

Price per Contract

Exercise Price

Expiration Date

Did you purchase shares of MiMedx Group, Inc. (2018) prior to the Class Period?

Yes

Are you a current or former employee of MiMedx Group, Inc. (2018)?

Yes

The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.

I agree to the KTMC
disclaimer

Yes

I would like to receive
new case alerts by email

Yes

Submit Your Information

COMPANY	MiMedx Group Inc.
COURT	United States District Court for the Northern District of Georgia
CASE NUMBER	18-cv-00830
JUDGE	The Honorable William McCrary Ray II
CLASS PERIOD	March 7, 2013 - June 29, 2018
SECURITY TYPE	Common Stock

Case Background:

On February 23, 2018, the initial complaint in this securities class action was filed against MiMedx Group Inc. (“MiMedx” or the “Company”), and certain of MiMedx’s directors and officers, asserting violations of sections 10(b) and 20(a) of the Securities Exchange Act. The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that (i) MiMedx was engaged in a "channel-stuffing" scheme designed to inappropriately recognize revenue that had not yet been realized; (ii) the Company lacked adequate internal controls over financial reporting; and (iii) that as a result of the foregoing, MiMedx's publicly disseminated financial statements were materially false and misleading.

This securities class action lawsuit was brought on behalf of all persons or entities that purchased or otherwise acquired the publicly traded common stock of MiMedx between March 7, 2013 and June 29, 2018, inclusive, and who were damaged thereby.

Current Status of Case:

On March 30, 2020 Plaintiffs filed a Second Amended Complaint. Defendants filed a Motion to Dismiss Plaintiffs’ Amended Complaint May 29, 2020. On October 5, 2020, the Court granted the parties Joint Motion to Temporarily Stay Proceedings due to being in the process of scheduling a mediation. On March 25, 2021 Defendants’ Motion to Dismiss was granted. . Plaintiffs filed a Motion for Relief from Judgment and for Leave to Amend on April 22, 2021. A hearing is scheduled on the Motion for Relief from Judgment on July 25, 2021. The Court took the matter under advisement and will endeavor to issue a ruling by the end of November. This action is ongoing.

If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq. (484) 270-1453; or via e-mail at info@ktmc.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.